Global Gliclazide Sustained-release Tablet Supply, Demand and Key Producers, 2023-2029
The global Gliclazide Sustained-release Tablet market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Gliclazide Sustained-release Tablet production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gliclazide Sustained-release Tablet, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gliclazide Sustained-release Tablet that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gliclazide Sustained-release Tablet total production and demand, 2018-2029, (K Units)
Global Gliclazide Sustained-release Tablet total production value, 2018-2029, (USD Million)
Global Gliclazide Sustained-release Tablet production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gliclazide Sustained-release Tablet domestic production, consumption, key domestic manufacturers and share
Global Gliclazide Sustained-release Tablet production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Gliclazide Sustained-release Tablet market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare and Lukang Jituan Saite Yaoye, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gliclazide Sustained-release Tablet market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gliclazide Sustained-release Tablet Market, By Region:
1. How big is the global Gliclazide Sustained-release Tablet market?
2. What is the demand of the global Gliclazide Sustained-release Tablet market?
3. What is the year over year growth of the global Gliclazide Sustained-release Tablet market?
4. What is the production and production value of the global Gliclazide Sustained-release Tablet market?
5. Who are the key producers in the global Gliclazide Sustained-release Tablet market?
6. What are the growth factors driving the market demand?
This report studies the global Gliclazide Sustained-release Tablet production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gliclazide Sustained-release Tablet, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gliclazide Sustained-release Tablet that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gliclazide Sustained-release Tablet total production and demand, 2018-2029, (K Units)
Global Gliclazide Sustained-release Tablet total production value, 2018-2029, (USD Million)
Global Gliclazide Sustained-release Tablet production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gliclazide Sustained-release Tablet domestic production, consumption, key domestic manufacturers and share
Global Gliclazide Sustained-release Tablet production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gliclazide Sustained-release Tablet production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Gliclazide Sustained-release Tablet market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare and Lukang Jituan Saite Yaoye, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gliclazide Sustained-release Tablet market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gliclazide Sustained-release Tablet Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 30mg
- 60mg
- Other
- Hospital
- Clinic
- Other
- Servier Laboratories
- Torrent Pharmaceuticals
- Aurobindo Pharma
- Teva
- Zydus Cadila Healthcare
- Sanofi S.A.
- Mylan Pharmaceuticals
- Accord Healthcare
- Lukang Jituan Saite Yaoye
- Shijiazhuang SIYAO
- Yiling Pharmaceutical
1. How big is the global Gliclazide Sustained-release Tablet market?
2. What is the demand of the global Gliclazide Sustained-release Tablet market?
3. What is the year over year growth of the global Gliclazide Sustained-release Tablet market?
4. What is the production and production value of the global Gliclazide Sustained-release Tablet market?
5. Who are the key producers in the global Gliclazide Sustained-release Tablet market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gliclazide Sustained-release Tablet Introduction
1.2 World Gliclazide Sustained-release Tablet Supply & Forecast
1.2.1 World Gliclazide Sustained-release Tablet Production Value (2018 & 2022 & 2029)
1.2.2 World Gliclazide Sustained-release Tablet Production (2018-2029)
1.2.3 World Gliclazide Sustained-release Tablet Pricing Trends (2018-2029)
1.3 World Gliclazide Sustained-release Tablet Production by Region (Based on Production Site)
1.3.1 World Gliclazide Sustained-release Tablet Production Value by Region (2018-2029)
1.3.2 World Gliclazide Sustained-release Tablet Production by Region (2018-2029)
1.3.3 World Gliclazide Sustained-release Tablet Average Price by Region (2018-2029)
1.3.4 North America Gliclazide Sustained-release Tablet Production (2018-2029)
1.3.5 Europe Gliclazide Sustained-release Tablet Production (2018-2029)
1.3.6 China Gliclazide Sustained-release Tablet Production (2018-2029)
1.3.7 Japan Gliclazide Sustained-release Tablet Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gliclazide Sustained-release Tablet Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gliclazide Sustained-release Tablet Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gliclazide Sustained-release Tablet Demand (2018-2029)
2.2 World Gliclazide Sustained-release Tablet Consumption by Region
2.2.1 World Gliclazide Sustained-release Tablet Consumption by Region (2018-2023)
2.2.2 World Gliclazide Sustained-release Tablet Consumption Forecast by Region (2024-2029)
2.3 United States Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.4 China Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.5 Europe Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.6 Japan Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.7 South Korea Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.8 ASEAN Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.9 India Gliclazide Sustained-release Tablet Consumption (2018-2029)
3 WORLD GLICLAZIDE SUSTAINED-RELEASE TABLET MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gliclazide Sustained-release Tablet Production Value by Manufacturer (2018-2023)
3.2 World Gliclazide Sustained-release Tablet Production by Manufacturer (2018-2023)
3.3 World Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023)
3.4 Gliclazide Sustained-release Tablet Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gliclazide Sustained-release Tablet Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gliclazide Sustained-release Tablet in 2022
3.5.3 Global Concentration Ratios (CR8) for Gliclazide Sustained-release Tablet in 2022
3.6 Gliclazide Sustained-release Tablet Market: Overall Company Footprint Analysis
3.6.1 Gliclazide Sustained-release Tablet Market: Region Footprint
3.6.2 Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
3.6.3 Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gliclazide Sustained-release Tablet Production Value Comparison
4.1.1 United States VS China: Gliclazide Sustained-release Tablet Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Gliclazide Sustained-release Tablet Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Gliclazide Sustained-release Tablet Production Comparison
4.2.1 United States VS China: Gliclazide Sustained-release Tablet Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gliclazide Sustained-release Tablet Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Gliclazide Sustained-release Tablet Consumption Comparison
4.3.1 United States VS China: Gliclazide Sustained-release Tablet Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Gliclazide Sustained-release Tablet Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Gliclazide Sustained-release Tablet Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
4.4.3 United States Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
4.5 China Based Gliclazide Sustained-release Tablet Manufacturers and Market Share
4.5.1 China Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
4.5.3 China Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
4.6 Rest of World Based Gliclazide Sustained-release Tablet Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gliclazide Sustained-release Tablet Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 30mg
5.2.2 60mg
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Gliclazide Sustained-release Tablet Production by Type (2018-2029)
5.3.2 World Gliclazide Sustained-release Tablet Production Value by Type (2018-2029)
5.3.3 World Gliclazide Sustained-release Tablet Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gliclazide Sustained-release Tablet Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Gliclazide Sustained-release Tablet Production by Application (2018-2029)
6.3.2 World Gliclazide Sustained-release Tablet Production Value by Application (2018-2029)
6.3.3 World Gliclazide Sustained-release Tablet Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Servier Laboratories
7.1.1 Servier Laboratories Details
7.1.2 Servier Laboratories Major Business
7.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
7.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Servier Laboratories Recent Developments/Updates
7.1.6 Servier Laboratories Competitive Strengths & Weaknesses
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Details
7.2.2 Torrent Pharmaceuticals Major Business
7.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
7.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Details
7.3.2 Aurobindo Pharma Major Business
7.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
7.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Aurobindo Pharma Recent Developments/Updates
7.3.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva Gliclazide Sustained-release Tablet Product and Services
7.4.4 Teva Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Zydus Cadila Healthcare
7.5.1 Zydus Cadila Healthcare Details
7.5.2 Zydus Cadila Healthcare Major Business
7.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
7.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Zydus Cadila Healthcare Recent Developments/Updates
7.5.6 Zydus Cadila Healthcare Competitive Strengths & Weaknesses
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Details
7.6.2 Sanofi S.A. Major Business
7.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
7.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi S.A. Recent Developments/Updates
7.6.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.7 Mylan Pharmaceuticals
7.7.1 Mylan Pharmaceuticals Details
7.7.2 Mylan Pharmaceuticals Major Business
7.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
7.7.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Mylan Pharmaceuticals Recent Developments/Updates
7.7.6 Mylan Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Accord Healthcare
7.8.1 Accord Healthcare Details
7.8.2 Accord Healthcare Major Business
7.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
7.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Accord Healthcare Recent Developments/Updates
7.8.6 Accord Healthcare Competitive Strengths & Weaknesses
7.9 Lukang Jituan Saite Yaoye
7.9.1 Lukang Jituan Saite Yaoye Details
7.9.2 Lukang Jituan Saite Yaoye Major Business
7.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
7.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
7.9.6 Lukang Jituan Saite Yaoye Competitive Strengths & Weaknesses
7.10 Shijiazhuang SIYAO
7.10.1 Shijiazhuang SIYAO Details
7.10.2 Shijiazhuang SIYAO Major Business
7.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
7.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shijiazhuang SIYAO Recent Developments/Updates
7.10.6 Shijiazhuang SIYAO Competitive Strengths & Weaknesses
7.11 Yiling Pharmaceutical
7.11.1 Yiling Pharmaceutical Details
7.11.2 Yiling Pharmaceutical Major Business
7.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
7.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Yiling Pharmaceutical Recent Developments/Updates
7.11.6 Yiling Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gliclazide Sustained-release Tablet Industry Chain
8.2 Gliclazide Sustained-release Tablet Upstream Analysis
8.2.1 Gliclazide Sustained-release Tablet Core Raw Materials
8.2.2 Main Manufacturers of Gliclazide Sustained-release Tablet Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gliclazide Sustained-release Tablet Production Mode
8.6 Gliclazide Sustained-release Tablet Procurement Model
8.7 Gliclazide Sustained-release Tablet Industry Sales Model and Sales Channels
8.7.1 Gliclazide Sustained-release Tablet Sales Model
8.7.2 Gliclazide Sustained-release Tablet Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gliclazide Sustained-release Tablet Introduction
1.2 World Gliclazide Sustained-release Tablet Supply & Forecast
1.2.1 World Gliclazide Sustained-release Tablet Production Value (2018 & 2022 & 2029)
1.2.2 World Gliclazide Sustained-release Tablet Production (2018-2029)
1.2.3 World Gliclazide Sustained-release Tablet Pricing Trends (2018-2029)
1.3 World Gliclazide Sustained-release Tablet Production by Region (Based on Production Site)
1.3.1 World Gliclazide Sustained-release Tablet Production Value by Region (2018-2029)
1.3.2 World Gliclazide Sustained-release Tablet Production by Region (2018-2029)
1.3.3 World Gliclazide Sustained-release Tablet Average Price by Region (2018-2029)
1.3.4 North America Gliclazide Sustained-release Tablet Production (2018-2029)
1.3.5 Europe Gliclazide Sustained-release Tablet Production (2018-2029)
1.3.6 China Gliclazide Sustained-release Tablet Production (2018-2029)
1.3.7 Japan Gliclazide Sustained-release Tablet Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gliclazide Sustained-release Tablet Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gliclazide Sustained-release Tablet Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gliclazide Sustained-release Tablet Demand (2018-2029)
2.2 World Gliclazide Sustained-release Tablet Consumption by Region
2.2.1 World Gliclazide Sustained-release Tablet Consumption by Region (2018-2023)
2.2.2 World Gliclazide Sustained-release Tablet Consumption Forecast by Region (2024-2029)
2.3 United States Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.4 China Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.5 Europe Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.6 Japan Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.7 South Korea Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.8 ASEAN Gliclazide Sustained-release Tablet Consumption (2018-2029)
2.9 India Gliclazide Sustained-release Tablet Consumption (2018-2029)
3 WORLD GLICLAZIDE SUSTAINED-RELEASE TABLET MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gliclazide Sustained-release Tablet Production Value by Manufacturer (2018-2023)
3.2 World Gliclazide Sustained-release Tablet Production by Manufacturer (2018-2023)
3.3 World Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023)
3.4 Gliclazide Sustained-release Tablet Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gliclazide Sustained-release Tablet Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gliclazide Sustained-release Tablet in 2022
3.5.3 Global Concentration Ratios (CR8) for Gliclazide Sustained-release Tablet in 2022
3.6 Gliclazide Sustained-release Tablet Market: Overall Company Footprint Analysis
3.6.1 Gliclazide Sustained-release Tablet Market: Region Footprint
3.6.2 Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
3.6.3 Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gliclazide Sustained-release Tablet Production Value Comparison
4.1.1 United States VS China: Gliclazide Sustained-release Tablet Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Gliclazide Sustained-release Tablet Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Gliclazide Sustained-release Tablet Production Comparison
4.2.1 United States VS China: Gliclazide Sustained-release Tablet Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gliclazide Sustained-release Tablet Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Gliclazide Sustained-release Tablet Consumption Comparison
4.3.1 United States VS China: Gliclazide Sustained-release Tablet Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Gliclazide Sustained-release Tablet Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Gliclazide Sustained-release Tablet Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
4.4.3 United States Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
4.5 China Based Gliclazide Sustained-release Tablet Manufacturers and Market Share
4.5.1 China Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
4.5.3 China Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
4.6 Rest of World Based Gliclazide Sustained-release Tablet Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gliclazide Sustained-release Tablet Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 30mg
5.2.2 60mg
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Gliclazide Sustained-release Tablet Production by Type (2018-2029)
5.3.2 World Gliclazide Sustained-release Tablet Production Value by Type (2018-2029)
5.3.3 World Gliclazide Sustained-release Tablet Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gliclazide Sustained-release Tablet Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Gliclazide Sustained-release Tablet Production by Application (2018-2029)
6.3.2 World Gliclazide Sustained-release Tablet Production Value by Application (2018-2029)
6.3.3 World Gliclazide Sustained-release Tablet Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Servier Laboratories
7.1.1 Servier Laboratories Details
7.1.2 Servier Laboratories Major Business
7.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
7.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Servier Laboratories Recent Developments/Updates
7.1.6 Servier Laboratories Competitive Strengths & Weaknesses
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Details
7.2.2 Torrent Pharmaceuticals Major Business
7.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
7.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Details
7.3.2 Aurobindo Pharma Major Business
7.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
7.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Aurobindo Pharma Recent Developments/Updates
7.3.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva Gliclazide Sustained-release Tablet Product and Services
7.4.4 Teva Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Zydus Cadila Healthcare
7.5.1 Zydus Cadila Healthcare Details
7.5.2 Zydus Cadila Healthcare Major Business
7.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
7.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Zydus Cadila Healthcare Recent Developments/Updates
7.5.6 Zydus Cadila Healthcare Competitive Strengths & Weaknesses
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Details
7.6.2 Sanofi S.A. Major Business
7.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
7.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi S.A. Recent Developments/Updates
7.6.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.7 Mylan Pharmaceuticals
7.7.1 Mylan Pharmaceuticals Details
7.7.2 Mylan Pharmaceuticals Major Business
7.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
7.7.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Mylan Pharmaceuticals Recent Developments/Updates
7.7.6 Mylan Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Accord Healthcare
7.8.1 Accord Healthcare Details
7.8.2 Accord Healthcare Major Business
7.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
7.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Accord Healthcare Recent Developments/Updates
7.8.6 Accord Healthcare Competitive Strengths & Weaknesses
7.9 Lukang Jituan Saite Yaoye
7.9.1 Lukang Jituan Saite Yaoye Details
7.9.2 Lukang Jituan Saite Yaoye Major Business
7.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
7.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
7.9.6 Lukang Jituan Saite Yaoye Competitive Strengths & Weaknesses
7.10 Shijiazhuang SIYAO
7.10.1 Shijiazhuang SIYAO Details
7.10.2 Shijiazhuang SIYAO Major Business
7.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
7.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shijiazhuang SIYAO Recent Developments/Updates
7.10.6 Shijiazhuang SIYAO Competitive Strengths & Weaknesses
7.11 Yiling Pharmaceutical
7.11.1 Yiling Pharmaceutical Details
7.11.2 Yiling Pharmaceutical Major Business
7.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
7.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Yiling Pharmaceutical Recent Developments/Updates
7.11.6 Yiling Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gliclazide Sustained-release Tablet Industry Chain
8.2 Gliclazide Sustained-release Tablet Upstream Analysis
8.2.1 Gliclazide Sustained-release Tablet Core Raw Materials
8.2.2 Main Manufacturers of Gliclazide Sustained-release Tablet Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gliclazide Sustained-release Tablet Production Mode
8.6 Gliclazide Sustained-release Tablet Procurement Model
8.7 Gliclazide Sustained-release Tablet Industry Sales Model and Sales Channels
8.7.1 Gliclazide Sustained-release Tablet Sales Model
8.7.2 Gliclazide Sustained-release Tablet Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gliclazide Sustained-release Tablet Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Gliclazide Sustained-release Tablet Production Value by Region (2018-2023) & (USD Million)
Table 3. World Gliclazide Sustained-release Tablet Production Value by Region (2024-2029) & (USD Million)
Table 4. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2018-2023)
Table 5. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2024-2029)
Table 6. World Gliclazide Sustained-release Tablet Production by Region (2018-2023) & (K Units)
Table 7. World Gliclazide Sustained-release Tablet Production by Region (2024-2029) & (K Units)
Table 8. World Gliclazide Sustained-release Tablet Production Market Share by Region (2018-2023)
Table 9. World Gliclazide Sustained-release Tablet Production Market Share by Region (2024-2029)
Table 10. World Gliclazide Sustained-release Tablet Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Gliclazide Sustained-release Tablet Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Gliclazide Sustained-release Tablet Major Market Trends
Table 13. World Gliclazide Sustained-release Tablet Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Gliclazide Sustained-release Tablet Consumption by Region (2018-2023) & (K Units)
Table 15. World Gliclazide Sustained-release Tablet Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Gliclazide Sustained-release Tablet Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Gliclazide Sustained-release Tablet Producers in 2022
Table 18. World Gliclazide Sustained-release Tablet Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Gliclazide Sustained-release Tablet Producers in 2022
Table 20. World Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Gliclazide Sustained-release Tablet Company Evaluation Quadrant
Table 22. World Gliclazide Sustained-release Tablet Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Gliclazide Sustained-release Tablet Production Site of Key Manufacturer
Table 24. Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
Table 25. Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
Table 26. Gliclazide Sustained-release Tablet Competitive Factors
Table 27. Gliclazide Sustained-release Tablet New Entrant and Capacity Expansion Plans
Table 28. Gliclazide Sustained-release Tablet Mergers & Acquisitions Activity
Table 29. United States VS China Gliclazide Sustained-release Tablet Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Gliclazide Sustained-release Tablet Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Gliclazide Sustained-release Tablet Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
Table 37. China Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
Table 42. Rest of World Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
Table 47. World Gliclazide Sustained-release Tablet Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Gliclazide Sustained-release Tablet Production by Type (2018-2023) & (K Units)
Table 49. World Gliclazide Sustained-release Tablet Production by Type (2024-2029) & (K Units)
Table 50. World Gliclazide Sustained-release Tablet Production Value by Type (2018-2023) & (USD Million)
Table 51. World Gliclazide Sustained-release Tablet Production Value by Type (2024-2029) & (USD Million)
Table 52. World Gliclazide Sustained-release Tablet Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Gliclazide Sustained-release Tablet Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Gliclazide Sustained-release Tablet Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Gliclazide Sustained-release Tablet Production by Application (2018-2023) & (K Units)
Table 56. World Gliclazide Sustained-release Tablet Production by Application (2024-2029) & (K Units)
Table 57. World Gliclazide Sustained-release Tablet Production Value by Application (2018-2023) & (USD Million)
Table 58. World Gliclazide Sustained-release Tablet Production Value by Application (2024-2029) & (USD Million)
Table 59. World Gliclazide Sustained-release Tablet Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Gliclazide Sustained-release Tablet Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Servier Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Servier Laboratories Major Business
Table 63. Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
Table 64. Servier Laboratories Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Servier Laboratories Recent Developments/Updates
Table 66. Servier Laboratories Competitive Strengths & Weaknesses
Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Torrent Pharmaceuticals Major Business
Table 69. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
Table 70. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Torrent Pharmaceuticals Recent Developments/Updates
Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Aurobindo Pharma Major Business
Table 75. Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
Table 76. Aurobindo Pharma Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Aurobindo Pharma Recent Developments/Updates
Table 78. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva Gliclazide Sustained-release Tablet Product and Services
Table 82. Teva Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Zydus Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 86. Zydus Cadila Healthcare Major Business
Table 87. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
Table 88. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Zydus Cadila Healthcare Recent Developments/Updates
Table 90. Zydus Cadila Healthcare Competitive Strengths & Weaknesses
Table 91. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 92. Sanofi S.A. Major Business
Table 93. Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
Table 94. Sanofi S.A. Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sanofi S.A. Recent Developments/Updates
Table 96. Sanofi S.A. Competitive Strengths & Weaknesses
Table 97. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Mylan Pharmaceuticals Major Business
Table 99. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
Table 100. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Mylan Pharmaceuticals Recent Developments/Updates
Table 102. Mylan Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. Accord Healthcare Major Business
Table 105. Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
Table 106. Accord Healthcare Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Accord Healthcare Recent Developments/Updates
Table 108. Accord Healthcare Competitive Strengths & Weaknesses
Table 109. Lukang Jituan Saite Yaoye Basic Information, Manufacturing Base and Competitors
Table 110. Lukang Jituan Saite Yaoye Major Business
Table 111. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
Table 112. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Lukang Jituan Saite Yaoye Recent Developments/Updates
Table 114. Lukang Jituan Saite Yaoye Competitive Strengths & Weaknesses
Table 115. Shijiazhuang SIYAO Basic Information, Manufacturing Base and Competitors
Table 116. Shijiazhuang SIYAO Major Business
Table 117. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
Table 118. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shijiazhuang SIYAO Recent Developments/Updates
Table 120. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 121. Yiling Pharmaceutical Major Business
Table 122. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
Table 123. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Gliclazide Sustained-release Tablet Upstream (Raw Materials)
Table 125. Gliclazide Sustained-release Tablet Typical Customers
Table 126. Gliclazide Sustained-release Tablet Typical Distributors
Table 1. World Gliclazide Sustained-release Tablet Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Gliclazide Sustained-release Tablet Production Value by Region (2018-2023) & (USD Million)
Table 3. World Gliclazide Sustained-release Tablet Production Value by Region (2024-2029) & (USD Million)
Table 4. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2018-2023)
Table 5. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2024-2029)
Table 6. World Gliclazide Sustained-release Tablet Production by Region (2018-2023) & (K Units)
Table 7. World Gliclazide Sustained-release Tablet Production by Region (2024-2029) & (K Units)
Table 8. World Gliclazide Sustained-release Tablet Production Market Share by Region (2018-2023)
Table 9. World Gliclazide Sustained-release Tablet Production Market Share by Region (2024-2029)
Table 10. World Gliclazide Sustained-release Tablet Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Gliclazide Sustained-release Tablet Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Gliclazide Sustained-release Tablet Major Market Trends
Table 13. World Gliclazide Sustained-release Tablet Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Gliclazide Sustained-release Tablet Consumption by Region (2018-2023) & (K Units)
Table 15. World Gliclazide Sustained-release Tablet Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Gliclazide Sustained-release Tablet Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Gliclazide Sustained-release Tablet Producers in 2022
Table 18. World Gliclazide Sustained-release Tablet Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Gliclazide Sustained-release Tablet Producers in 2022
Table 20. World Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Gliclazide Sustained-release Tablet Company Evaluation Quadrant
Table 22. World Gliclazide Sustained-release Tablet Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Gliclazide Sustained-release Tablet Production Site of Key Manufacturer
Table 24. Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
Table 25. Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
Table 26. Gliclazide Sustained-release Tablet Competitive Factors
Table 27. Gliclazide Sustained-release Tablet New Entrant and Capacity Expansion Plans
Table 28. Gliclazide Sustained-release Tablet Mergers & Acquisitions Activity
Table 29. United States VS China Gliclazide Sustained-release Tablet Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Gliclazide Sustained-release Tablet Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Gliclazide Sustained-release Tablet Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
Table 37. China Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
Table 42. Rest of World Based Gliclazide Sustained-release Tablet Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share (2018-2023)
Table 47. World Gliclazide Sustained-release Tablet Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Gliclazide Sustained-release Tablet Production by Type (2018-2023) & (K Units)
Table 49. World Gliclazide Sustained-release Tablet Production by Type (2024-2029) & (K Units)
Table 50. World Gliclazide Sustained-release Tablet Production Value by Type (2018-2023) & (USD Million)
Table 51. World Gliclazide Sustained-release Tablet Production Value by Type (2024-2029) & (USD Million)
Table 52. World Gliclazide Sustained-release Tablet Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Gliclazide Sustained-release Tablet Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Gliclazide Sustained-release Tablet Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Gliclazide Sustained-release Tablet Production by Application (2018-2023) & (K Units)
Table 56. World Gliclazide Sustained-release Tablet Production by Application (2024-2029) & (K Units)
Table 57. World Gliclazide Sustained-release Tablet Production Value by Application (2018-2023) & (USD Million)
Table 58. World Gliclazide Sustained-release Tablet Production Value by Application (2024-2029) & (USD Million)
Table 59. World Gliclazide Sustained-release Tablet Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Gliclazide Sustained-release Tablet Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Servier Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Servier Laboratories Major Business
Table 63. Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
Table 64. Servier Laboratories Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Servier Laboratories Recent Developments/Updates
Table 66. Servier Laboratories Competitive Strengths & Weaknesses
Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Torrent Pharmaceuticals Major Business
Table 69. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
Table 70. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Torrent Pharmaceuticals Recent Developments/Updates
Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Aurobindo Pharma Major Business
Table 75. Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
Table 76. Aurobindo Pharma Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Aurobindo Pharma Recent Developments/Updates
Table 78. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva Gliclazide Sustained-release Tablet Product and Services
Table 82. Teva Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Zydus Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 86. Zydus Cadila Healthcare Major Business
Table 87. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
Table 88. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Zydus Cadila Healthcare Recent Developments/Updates
Table 90. Zydus Cadila Healthcare Competitive Strengths & Weaknesses
Table 91. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 92. Sanofi S.A. Major Business
Table 93. Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
Table 94. Sanofi S.A. Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sanofi S.A. Recent Developments/Updates
Table 96. Sanofi S.A. Competitive Strengths & Weaknesses
Table 97. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Mylan Pharmaceuticals Major Business
Table 99. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
Table 100. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Mylan Pharmaceuticals Recent Developments/Updates
Table 102. Mylan Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. Accord Healthcare Major Business
Table 105. Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
Table 106. Accord Healthcare Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Accord Healthcare Recent Developments/Updates
Table 108. Accord Healthcare Competitive Strengths & Weaknesses
Table 109. Lukang Jituan Saite Yaoye Basic Information, Manufacturing Base and Competitors
Table 110. Lukang Jituan Saite Yaoye Major Business
Table 111. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
Table 112. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Lukang Jituan Saite Yaoye Recent Developments/Updates
Table 114. Lukang Jituan Saite Yaoye Competitive Strengths & Weaknesses
Table 115. Shijiazhuang SIYAO Basic Information, Manufacturing Base and Competitors
Table 116. Shijiazhuang SIYAO Major Business
Table 117. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
Table 118. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shijiazhuang SIYAO Recent Developments/Updates
Table 120. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 121. Yiling Pharmaceutical Major Business
Table 122. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
Table 123. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Gliclazide Sustained-release Tablet Upstream (Raw Materials)
Table 125. Gliclazide Sustained-release Tablet Typical Customers
Table 126. Gliclazide Sustained-release Tablet Typical Distributors
LIST OF FIGURES
Figure 1. Gliclazide Sustained-release Tablet Picture
Figure 2. World Gliclazide Sustained-release Tablet Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gliclazide Sustained-release Tablet Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 5. World Gliclazide Sustained-release Tablet Average Price (2018-2029) & (US$/Unit)
Figure 6. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2018-2029)
Figure 7. World Gliclazide Sustained-release Tablet Production Market Share by Region (2018-2029)
Figure 8. North America Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 9. Europe Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 10. China Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 11. Japan Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 12. Gliclazide Sustained-release Tablet Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 15. World Gliclazide Sustained-release Tablet Consumption Market Share by Region (2018-2029)
Figure 16. United States Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 17. China Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 18. Europe Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 19. Japan Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 20. South Korea Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 22. India Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Gliclazide Sustained-release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gliclazide Sustained-release Tablet Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gliclazide Sustained-release Tablet Markets in 2022
Figure 26. United States VS China: Gliclazide Sustained-release Tablet Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Gliclazide Sustained-release Tablet Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gliclazide Sustained-release Tablet Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
Figure 30. China Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
Figure 32. World Gliclazide Sustained-release Tablet Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Gliclazide Sustained-release Tablet Production Value Market Share by Type in 2022
Figure 34. 30mg
Figure 35. 60mg
Figure 36. Other
Figure 37. World Gliclazide Sustained-release Tablet Production Market Share by Type (2018-2029)
Figure 38. World Gliclazide Sustained-release Tablet Production Value Market Share by Type (2018-2029)
Figure 39. World Gliclazide Sustained-release Tablet Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Gliclazide Sustained-release Tablet Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Gliclazide Sustained-release Tablet Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Gliclazide Sustained-release Tablet Production Market Share by Application (2018-2029)
Figure 46. World Gliclazide Sustained-release Tablet Production Value Market Share by Application (2018-2029)
Figure 47. World Gliclazide Sustained-release Tablet Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Gliclazide Sustained-release Tablet Industry Chain
Figure 49. Gliclazide Sustained-release Tablet Procurement Model
Figure 50. Gliclazide Sustained-release Tablet Sales Model
Figure 51. Gliclazide Sustained-release Tablet Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Gliclazide Sustained-release Tablet Picture
Figure 2. World Gliclazide Sustained-release Tablet Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gliclazide Sustained-release Tablet Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 5. World Gliclazide Sustained-release Tablet Average Price (2018-2029) & (US$/Unit)
Figure 6. World Gliclazide Sustained-release Tablet Production Value Market Share by Region (2018-2029)
Figure 7. World Gliclazide Sustained-release Tablet Production Market Share by Region (2018-2029)
Figure 8. North America Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 9. Europe Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 10. China Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 11. Japan Gliclazide Sustained-release Tablet Production (2018-2029) & (K Units)
Figure 12. Gliclazide Sustained-release Tablet Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 15. World Gliclazide Sustained-release Tablet Consumption Market Share by Region (2018-2029)
Figure 16. United States Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 17. China Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 18. Europe Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 19. Japan Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 20. South Korea Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 22. India Gliclazide Sustained-release Tablet Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Gliclazide Sustained-release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gliclazide Sustained-release Tablet Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gliclazide Sustained-release Tablet Markets in 2022
Figure 26. United States VS China: Gliclazide Sustained-release Tablet Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Gliclazide Sustained-release Tablet Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gliclazide Sustained-release Tablet Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
Figure 30. China Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Gliclazide Sustained-release Tablet Production Market Share 2022
Figure 32. World Gliclazide Sustained-release Tablet Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Gliclazide Sustained-release Tablet Production Value Market Share by Type in 2022
Figure 34. 30mg
Figure 35. 60mg
Figure 36. Other
Figure 37. World Gliclazide Sustained-release Tablet Production Market Share by Type (2018-2029)
Figure 38. World Gliclazide Sustained-release Tablet Production Value Market Share by Type (2018-2029)
Figure 39. World Gliclazide Sustained-release Tablet Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Gliclazide Sustained-release Tablet Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Gliclazide Sustained-release Tablet Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Gliclazide Sustained-release Tablet Production Market Share by Application (2018-2029)
Figure 46. World Gliclazide Sustained-release Tablet Production Value Market Share by Application (2018-2029)
Figure 47. World Gliclazide Sustained-release Tablet Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Gliclazide Sustained-release Tablet Industry Chain
Figure 49. Gliclazide Sustained-release Tablet Procurement Model
Figure 50. Gliclazide Sustained-release Tablet Sales Model
Figure 51. Gliclazide Sustained-release Tablet Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
